Charles Schwab Investment Management Inc Acrivon Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 113,840 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
113,840
Previous 116,253
2.08%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ACRV
# of Institutions
59Shares Held
23.3MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA8.34MShares$00.0% of portfolio
-
Perceptive Advisors LLC New York, NY5.36MShares$00.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA2.12MShares$00.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.12MShares$00.0% of portfolio
-
Wellington Management Group LLP Boston, MA888KShares$00.0% of portfolio